- Optimal time on HAART for prevention of mother-to-child transmission of HIVCarla J Chibwesha
University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
J Acquir Immune Defic Syndr 58:224-8. 2011..To determine the impact of time between initiating highly active antiretroviral therapy (HAART) and delivery-duration of antenatal HAART-on perinatal HIV infection...
- See-and-treat approaches to cervical cancer prevention for HIV-infected womenCarla J Chibwesha
University of Alabama at Birmingham School of Medicine, USA
Curr HIV/AIDS Rep 8:192-9. 2011..Studies informing best practice guidelines on when to start, when to stop, and how frequently to screen HIV-infected women within the see-and-treat paradigm would be of great value...
- Modern contraceptive and dual method use among HIV-infected women in Lusaka, ZambiaCarla J Chibwesha
University of Alabama School of Medicine, Birmingham, AL 35294, USA
Infect Dis Obstet Gynecol 2011:261453. 2011..6% of these women successfully accessed services within 90 days. Unmet contraceptive need remains high among HIV-infected women. Additional efforts are needed to promote reproductive health, particularly dual method use...
- Implementation of the Zambia electronic perinatal record system for comprehensive prenatal and delivery careBenjamin H Chi
Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
Int J Gynaecol Obstet 113:131-6. 2011..To characterize prenatal and delivery care in an urban African setting...